{
    "organizations": [],
    "uuid": "edab68812beba51900b3ef42040519cffcf479b8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-hisoar-pharmaceutical-pla/brief-zhejiang-hisoar-pharmaceutical-plans-share-buyback-idUSH9N1PZ00J",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Hisoar Pharmaceutical Plans Share Buyback",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Zhejiang Hisoar Pharmaceutical Co Ltd :\n* SAYS IT PLANS TO BUY BACK SHARES FOR UP TO 300 MILLION YUAN ($47.42 million) AT UP TO 7 YUAN PER SHARE WITHIN 12 MONTHS Source text in Chinese: bit.ly/2ElBZRb Further company coverage: ($1 = 6.3267 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-02-12T17:41:00.000+02:00",
    "crawled": "2018-02-13T15:43:03.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "zhejiang",
        "hisoar",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "plan",
        "buy",
        "back",
        "share",
        "million",
        "yuan",
        "million",
        "yuan",
        "per",
        "share",
        "within",
        "month",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}